Analyst Ratings for Apricus Biosciences (APRI)
APRI Rating Summary
APRI Price Target Summary
- Highest: $8.00 (Lazard Capital)
- Lowest: $6.00 (JMP Securities)
- Average: $6.67
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.67 (+102%)
Avg. $ Target:
$6.67 (+102%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/27/2012 | Lazard Capital | New Coverage | Buy (N/A) |
8.00 (N/A) |
3.12 | 3.30 | 5.77% | Details |
| 7/23/2012 | Ascendiant Capital | New Coverage | Strong Buy (N/A) |
6.00 (N/A) |
3.12 | 3.30 | 5.77% | Details |
| 6/14/2012 | JMP Securities | New Coverage | Market Outperform (N/A) |
6.00 (N/A) |
3.04 | 3.30 | 8.55% | Details |
| 6/6/2012 | Roth Capital | New Coverage | Buy (N/A) |
N/A (N/A) |
2.49 | 3.30 | 32.53% | Details |
| 12/14/2010 | Dawson James | New Coverage | Market Outperform (N/A) |
N/A (N/A) |
3.39 | 3.30 | -2.65% | Details |
